European Journal of Anaesthesiology 2003-03-01

High-affinity block of voltage-operated rat IIA neuronal sodium channels by 2,6 di-tert-butylphenol, a propofol analogue.

G Haeseler, M Leuwer

Index: Eur. J. Anaesthesiol. 20(3) , 220-4, (2003)

Full Text: HTML

Abstract

Propofol is a phenol derivative (2,6 di-isopropylphenol) with a unique effect profile including activating effects on GABA(A) and blocking effects on voltage-operated sodium channels. If the substituents in the 2- and the 6-positions are replaced by tert-butyl groups, the resulting phenol derivative, 2,6 di-tert-butylphenol, despite being a close structural propofol analogue, completely lacks GABA(A) receptor effects. The aim of this in vitro study was to investigate the effects of 2,6 di-tert-butylphenol on voltage-operated neuronal sodium channels in order to determine whether and, if so, how these structural changes alter the sodium channel-blocking effect seen with propofol.Whole-cell sodium inward currents through heterologously expressed rat type IIA sodium channels were recorded in the absence and presence of definite concentrations of 2,6 di-tert-butylphenol and propofol.When applied at concentrations > or = 30 micromol, 2,6 di-tert-butylphenol completely and irreversibly blocked sodium inward currents. The blockade equilibrium time was about 2 min. A partial washout was possible only if the application was stopped before the equilibrium of the blockade was achieved.2,6 Di-tert-butylphenol exerts a high-affinity block of neuronal sodium channels. Apparently, the slight structural differences of 2,6 di-tert-butylphenol in comparison with propofol--which account for the lack of GABA(A) receptor effects--enhance its voltage-operated sodium channel-blocking effects. As 2,6 di-tert-butylphenol is much more potent than most sodium channel blockers in clinical use, it might be of interest in the development of local anaesthetics.


Related Compounds

  • 2,6-Di-tert-butylp...

Related Articles:

Cellular apoptosis and cytotoxicity of phenolic compounds: a quantitative structure-activity relationship study.

2005-11-17

[J. Med. Chem. 48 , 7234-42, (2005)]

Carbonic anhydrase inhibitors. Inhibition of human erythrocyte isozymes I and II with a series of antioxidant phenols.

2009-04-15

[Bioorg. Med. Chem. 17 , 3207-11, (2009)]

Antioxidant activity of propofol and related monomeric and dimeric compounds.

2005-03-01

[Chem. Pharm. Bull. 53(3) , 344-6, (2005)]

[Regulation by an antioxidant of growth, composition, and physico-chemical features of lipids from Saccharomyces cerevisiae].

1996-02-01

[Dokl. Akad. Nauk. 346(5) , 705-7, (1996)]

Lipid peroxidation in erythrocyte membranes: cholesterol product analysis in photosensitized and xanthine oxidase-catalyzed reactions.

1987-06-01

[Lipids 22(6) , 401-8, (1987)]

More Articles...